Vascular Graft Solutions Overview
- Year Founded
-
2009

- Status
-
Acquired/Merged
- Employees
-
23

- Latest Deal Type
-
2ndary - Private
- Financing Rounds
-
7
- Investments
-
1
Vascular Graft Solutions General Information
Description
Developer of external stents and scaffolds designed for cardiac and vascular surgery. The company specializes in the development and marketing of surgical components and systems, enabling clients to treat Achilles heel of peripheral and heart bypass surgeries (CABG) vein graft diseases as well as improve and solve complex challenges such as surgical revascularization, vascular reconstruction, and arteriovenous fistula procedures.
Contact Information
Website
www.graftsolutions.com(Operating Subsidiary)
Corporate Office
- 24 Raul Wallenberg Street
- Tel Aviv 6971921
- Israel
Corporate Office
- 24 Raul Wallenberg Street
- Tel Aviv 6971921
- Israel
Vascular Graft Solutions Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Vascular Graft Solutions Patents
Vascular Graft Solutions Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2022202617-A1 | Asymmetric external support for stabilizing a vein graft used in a coronary arterial bypass graft (cabg) procedure, and applications thereof | Pending | 22-Apr-2021 | ||
CA-3155110-A1 | Asymmetric external support for stabilizing a vein graft used in a coronary arterial bypass graft (cabg) procedure, and applications thereof | Pending | 22-Apr-2021 | ||
JP-2022167849-A | Asymmetric external support for stabilizing vein graft used in coronary arterial bypass graft (cabg) procedure, and applications thereof | Pending | 22-Apr-2021 | ||
US-11291565-B1 | Asymmetric external support for stabilizing a vein graft used in a coronary arterial bypass graft (cabg) procedure, and applications thereof | Active | 22-Apr-2021 | ||
EP-4082449-A1 | Asymmetric external support for stabilizing a vein graft used in a coronary arterial bypass graft (cabg) procedure, and applications thereof | Active | 22-Apr-2021 | A61F2/064 |
Vascular Graft Solutions Signals
Vascular Graft Solutions Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Vascular Graft Solutions Investments (1)
Vascular Graft Solutions’s most recent deal was a Buyout/LBO with Neograft Technologies (Patents Portfolio). The deal was made on 06-Jan-2020.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Neograft Technologies (Patents Portfolio) | 06-Jan-2020 | Buyout/LBO | Buildings and Property |
Vascular Graft Solutions FAQs
-
When was Vascular Graft Solutions founded?
Vascular Graft Solutions was founded in 2009.
-
Where is Vascular Graft Solutions headquartered?
Vascular Graft Solutions is headquartered in Tel Aviv, Israel.
-
What is the size of Vascular Graft Solutions?
Vascular Graft Solutions has 23 total employees.
-
What industry is Vascular Graft Solutions in?
Vascular Graft Solutions’s primary industry is Surgical Devices.
-
Is Vascular Graft Solutions a private or public company?
Vascular Graft Solutions is a Private company.
-
What is Vascular Graft Solutions’s current revenue?
The current revenue for Vascular Graft Solutions is
. -
How much funding has Vascular Graft Solutions raised over time?
Vascular Graft Solutions has raised $1M.
-
Who are Vascular Graft Solutions’s investors?
GEOC Hengtong Investment and RAD BioMed have invested in Vascular Graft Solutions.
-
Who acquired Vascular Graft Solutions?
Vascular Graft Solutions was acquired by Cerba HealthCare.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »